Data protection Impressum

Healthcare

The Swiss Biotech Report 2026 reveals record sector revenues and a landmark year for private funding, as talent and international collaboration continue to underpin Switzerland's position at the forefront of global life sciences.

Swiss Biotech Report 2026: talent and tenacity drive record performance

5 May 2026

Medtronic celebrates ten million implantable devices produced in Tolochenaz, confirming the canton of Vaud as a global medtech manufacturing hub.

Medtronic reaches 10 million implantable devices produced in the canton of Vaud

4 May 2026

Top Stories Western Switzerland

Top Stories from Western Switzerland (April 2026)

29 April 2026

Lausanne's CHUV has become the first hospital in Western Switzerland to deploy the Da Vinci Single Port robotic surgical assistant, performing minimally invasive procedures through a single 2.7 cm incision or a natural orifice across six surgical specialties.

CHUV deploys Western Switzerland’s first single-port robotic surgical assistant

29 April 2026

Three Geneva-based start-ups have received seed funding through the FONGIT Innovation Fund (FIF), supporting innovations in olfactory diagnostics, AI-powered maritime chartering, and SME cybersecurity.

Geneva backs three start-ups tackling smell, shipping, and cyber threats

27 April 2026

Four early-stage projects from the canton of Vaud have each received a CHF 10,000 FIT Impact grant, supporting low-tech, high-impact innovations in medical education, speech therapy, science outreach, and biodiversity monitoring.

FIT Impact grants awarded to four Vaud-based low-tech innovation projects

21 April 2026

The applied research partnership between CSEM, the Insel Gruppe, and the University of Bern has been extended for three years, building on 32 medtech projects launched since 2023 and reinforcing Bern's ambition to become a leading international medical hub by 2030.

CSEM, Insel Gruppe, and University of Bern extend Bern medtech collaboration for three more years

20 April 2026

ONWARD Medical has secured EUR 40.6 million through an accelerated bookbuild offering led by a EUR 25 million investment from EQT Life Sciences, extending the company's cash runway into the first quarter of 2028.

ONWARD Medical raises EUR 40 million to extend ARC therapy commercialization

20 April 2026

Four life sciences projects were recognized at BIND – BioInnovation Day 2026, held at CHUV Lausanne on 1 April 2026, as the region's flagship academic innovation showcase drew 340 participants from academia, healthcare, industry, and investment.

BIND 2026 highlights Western Switzerland’s life sciences innovation pipeline

14 April 2026

Top Stories Western Switzerland

Top Stories from Western Switzerland (March 2026)

1 April 2026

1 2 3 4 5 … 25